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Abstract
The mouse (m) DC-SIGN family consists of several homologous type II transmembrane proteins
located in close proximity on chromosome 8 and having a single carboxyl terminal carbohydrate
recognition domain. We ®rst used transfected non-macrophage cell lines to compare the
polysaccharide and microbial uptake capacities of three of these lectinsÐDC-SIGN, SIGNR1 and
SIGNR3Ðto another homologue mLangerin. Each molecule shares a potential mannose-recognition
EPN-motif in its carbohydrate recognition domain. Using an anti-Tag antibody to follow Tag-labeled
transfectants, we found that each molecule could be internalized, although the rates differed.
However, mDC-SIGN was unable to take up FITC±dextran, FITC±ovalbumin, zymosan or heat-killed
Candida albicans. The other three lectins showed distinct carbohydrate recognition properties,
assessed by blocking FITC±dextran uptake at 37°C and by mannan binding activity at 4°C.
Furthermore, only SIGNR1 was ef®cient in mediating the capture by transfected cells of Gram-
negative bacteria, such as Escherichia coli and Salmonella typhimurium, while none of the lectins
tested were competent to capture Gram-positive bacteria, Staphylococcus aureus. Interestingly,
transfectants with SIGNR1 lacking the cytoplasmic domain were capable of binding FITC±zymosan
in a manner that was abolished by EDTA or mannan, but not laminarin. In addition, resident
peritoneal CD11b+ cells expressing SIGNR1 bound zymosan at 4°C in concert with a laminarin-
sensitive receptor. Therefore these homologous C-type lectins have distinct recognition patters for
microbes despite similarities in the carbohydrate recognition domains.
Introduction
C-type lectins are expressed in most cell types including
macrophages and dendritic cells (DCs), which must internal-
ize various glycoproteins and microbes for the purposes of
clearance and antigen presentation to T lymphocytes (1).
Human (h) DC-SIGN (CD209) is of special interest because it
is involved in the interaction of certain DCs with several
different pathogens including several viruses [HIV-1 (2), HCV
(3), dengue virus (4,5), CMV (6), ebola virus (7)] and other
microbes [mycobacteria (8,9), Leishmania (10) and candida
species (11)]. This type II transmembrane protein has a single
C-type lectin domain and is expressed on immature mono-
cyte-derived DCs.
Previously, we have cloned ®ve mouse hDC-SIGN homo-
logues that form a gene cluster in an ~210 kb region on
chromosome 8 (12). Only one of these named mDC-SIGN was
expressed in a restricted fashion in DCs, while the others had
a different tissue distribution and were termed SIGNR1,
SIGNR2, SIGNR3 and SIGNR4 for SIGN-related proteins.
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Despite similarities in the carbohydrate recognition domains
(CRDs) of the mouse homologues to hDC-SIGN, the mem-
brane proximal neck domains were much shorter.
It will be important to begin to identify the natural ligands for
this new family of C-type lectins. We and Geijtenbeek et al.
have recently reported that SIGNR1 is primarily expressed on
a subset of macrophages in spleen marginal zone and lymph
node medulla, and that SIGNR1 is involved in the uptake of
¯uorescence-labeled dextran (FITC±dextran) and capsular
polysaccharides of Streptococcus pneumoniae (13±15).
SIGNR1 dependent uptake was observed for both splenic
marginal zone macrophages in vivo and by cell lines
transfected with the SIGNR1 gene. Except for SIGNR4, the
mouse DC-SIGN family has an EPN motif that is postulated to
recognize mannose residues (16,17) (SIGNR4 contains a QPN
motif).
We now report on the recognition of polysaccharides and
microbes as well as endocytic capabilities of mDC-SIGN and
SIGNRs using transfected non-macrophage cell lines, so that
we could distinguish the function of the SIGN family from the
many other C-type lectins expressed by macrophages and
DCs. We were also interested in comparing mDC-SIGN,
SIGNR1 and SIGNR3 with mLangerin, another homologous
C-type lectin that has an EPN motif in its CRD but is expressed
on a distinct subset of DCs (12,18). We further show that
SIGNR1 is expressed by resident peritoneal CD11b+ cells and
recognizes zymosan in cooperation with laminarin-sensitive
receptor. Our results reveal differences in polysaccharide
recognition, endocytic capacities and microbe capture
among these lectins.
Methods
Cells and cultures
Human embryonic kidney HEK293T cells, African green
monkey kidney COS-7 cells, mouse ®broblast NIH3T3 cells
and Chinese hamster ovary CHO cells were maintained in
DMEM containing 10% FCS, 2 mM glutamine, 100 U/ml
penicillin and 100 mg/ml streptomycin. For CHO transfectants,
1 mg/ml of G418 (Sigma-Aldrich, Irvine, CA) was added to the
medium.
Vector constructions and transient expression of lectins
The coding sequences of mDC-SIGN, SIGNR1, SIGNR3 (12)
and mLangerin (18,19) were ampli®ed with KlenTaq DNA
polymerase (Sigma-Aldrich), and then cloned into pEF6/V5-
His (Invitrogen, Carlsbad, CA) and into pcDNA4/HisMax
(Invitrogen) to add V5 and Xpress Tag sequence at C-
terminus and N-terminus, respectively, according to the
manufacturer's protocol. Cloned cDNAs were transfected
with Lipofectamine 2000 reagent (Invitrogen) into HEK293T
and COS-7 or with TransFast transfection reagent (Promega,
Madison, WI) into NIH3T3. Following 24 h culture, cells were
collected, seeded either into tissue culture plates or onto poly
L-lysine (Sigma-Aldrich)-coated cover slips placed in culture
vessels at an appropriate cell density, and cultured for another
24 h. Transfection ef®ciencies were over 80% for HEK293T
cells, 25±30% for NIH3T3 cells and 35±45% for COS-7 cells,
as assessed by staining with anti-Tag mAbs.
Kinetic and microscopic analyses of internalization of C-type
lectins
Single cell suspensions of HEK293T cell transfectants were
incubated with 1 mg/ml of anti-V5 monoclonal antibody (mAb)
(mouse IgG2a; Invitrogen) for 30 min on ice, washed with cold
PBS and then incubated for various periods at 37°C to allow
internalization. At the end of the incubation, the cells were
stained with biotin±donkey F(ab¢)2 anti-mouse IgG antibody
(Jackson Immuno Research, West Grove, PA) and phyco-
erythrin-labeled (PE-) streptavidin (Jackson Immuno
Research), and then acquired with a FACSCalibur ¯ow
cytometer (Becton Dickinson, Mountain View, CA). The relative
amounts of remaining Ab on the cell surface were analyzed
with Flowjo (Tree Star, Inc., San Carlos, CA) or CELLQuest
(Becton Dickinson). In order to facilitate internalization,
transfectants were ®rst labeled with anti-V5 mAb and biotin±
donkey F(ab¢)2 anti-mouse IgG antibody before the incubation
at 37°C. Cells incubated at 4°C served as controls.
To detect the internalized lectins by immunostaining,
NIH3T3 transfectants on cover slips were ®rst treated with
1 mg/ml of anti-V5 antibody at 4°C for 30 min. After extensive
washes, the cells were incubated at 37°C for 60 min, ®xed with
ice-cold 3.7% formalin in phosphate-buffered saline (PBS)
followed by permeabilization by 0.01% saponin±PBS supple-
mented with 1% FCS. Then, cells were stained with biotin±
donkey F(ab¢)2 anti-mouse IgG antibody + Texas Red±
streptavidin (Dupont NEN, Boston, MA) in combination with
rat anti-transferrin receptor (TIB219) or LAMP-2 (ABL-93)
mAb + FITC-labeled donkey F(ab¢)2 anti-rat IgG (Jackson
Immuno Research) antibody. After mounting with 1% propyl
gallate (Wako, Osaka, Japan) in 50% glycerol, internalization
of lectins was analyzed with a deconvolution microscope
(BX51-FL: Olympus, Tokyo, Japan) using imaging software
(Openlab: Improvision, Coventry, UK). Images were stored
digitally and exported to Adobe Photoshop 7.0 for reproduc-
tion.
Capture of FITC±dextran and FITC±ovalbumin (OVA) by
transfectants
HEK293T cell transfectants expressing lectins with N-terminal
Xpress Tag were cultured in the presence of neutral FITC±
dextran (a-1,6-glucan) with molecular weight of 4.3 (FD-4), 40
(FD-40S), 250 (FD-250S), 500 (FD-500S) or 2000 kDa (FD-
2000S) (all from Sigma-Aldrich) at 16 mg/ml for 1 h or 1.6 mg/ml
for 12 h. FITC±OVA (Sigma-Aldrich) containing mainly
(Man)nGlcNAcGlcNAc-Asn was also added to the culture at
12.5 mg/ml for 12 h. Controls were HEK293T cells transfected
with pcDNA4/HisMax. After washing with PBS containing
5 mM EDTA to detach surface bound materials, cells were
analyzed with ¯ow cytometry. For inhibition assays, transfec-
tants were incubated with graded doses of b-glucan (from
barley: G-6513), mannan (from Saccharomyces cerevisiae:
M-7504), N-acetylglucosamine (GlcNAc: A-8625), N-acetyl-
galactosamine (GalNAc: A-2795) or Fucose (F-2252) (all from
Sigma-Aldrich) for 15 min at room temperature prior to the
addition of 16 mg/ml of FITC±dextran (molecular weight
2000 kDa) for 1 h at 37°C. Blocking ef®cacies were indicated
as percent inhibition according to the formula: (% FITC+ cells
in the control group without blocking agents ± that in
820 Microbial recognition by DC-SIGN homologs
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experimental groups) / that in control group 3 100. To examine
af®nity of lectin molecules for 2000 kDa FITC±dextran, the
transfectants were preincubated with graded doses of
mannan for 20 min at room temperature prior to the addition
of 16 mg/ml FITC±dextran and then cultured for 1 h at 37°C.
Binding assay using mannan agarose
Binding of the lectins to mannan agarose was tested as
described previously (18). Brie¯y, cell lysates in lysis buffer
(50 mM Tris±HCl pH 7.6, 150 mM NaCl, 25 mM CaCl2, 0.5%
Triton X-100, 1 mM PMSF and 20 mg/ml aprotinin) were
prepared from HEK293T cells transiently transfected with the
pcDNA4/HisMax constructs and then incubated with mannan
agarose beads (Sigma-Aldrich: M9917) for 12 h at 4°C. Then,
the agarose beads were washed with binding buffer (lysis
buffer including 0.05% Triton X-100) ®ve times with or without
25 mM EDTA. Proteins bound to the agarose beads were
separated on 12% SDS±PAGE under denaturing conditions
and transferred to Immobilon-P membrane (Millipore, Bedford,
MA). The membrane was probed with HRP-labeled anti-
Xpress antibody (Invitrogen) for Langerin, mDC-SIGN and
SIGNR3 or rabbit anti-SIGNR1 Ab (13) followed by HRP-anti-
rabbit IgG, then visualized by LumiGLO chemiluminescent
substrate (Cell Signaling Technology, Beverly, MA) according
to the manufacturer's protocols.
Uptake of microbes including zymosan
COS-7 transfectants with pcDNA4/HisMax constructs on
cover slips were cultured with Texas Red±zymosan A (four
particles/cell; Molecular Probes, Eugene, OR) or Texas Red±
E. coli (20 particles/cell; Molecular Probes) for 12 h in CO2
incubator. Salmonella typhimurium (strain GIFU5001)
obtained from Dr M. Mitsuyama (Kyoto University) was labeled
with FITC after heat treatment at 60°C for 30 min as described
(20), and added to the cell culture at 20 particles/cell for 6 h.
Candida albicans at the yeast stage was killed at 80°C for
30 min and added to the cell culture at two particles/cell for 4 h.
Bound and internalized C. albicans was visualized by staining
with FITC±anti-C. albicans antibody (Biogenesis, Kingston,
NH). Following extensive washes, cells were ®xed-permeabi-
lized and stained with anti-Xpress mAb (mouse IgG1;
Invitrogen) followed sequentially by biotin±donkey F(ab¢)2
anti-mouse IgG antibody (Jackson Immuno Research) and
FITC- or Texas Red±streptavidin to visualize transfectants
expressing lectins. After mounting with 1% propyl gallate in
50% glycerol, cells were analyzed with ¯uorescence micro-
scopy. In order to determine the internalization of FITC±
zymosan A (Molecular Probes), cells capturing zymosan were
treated with 0.05% trypan blue with 13 mM potassium
dihydrogen citrate in saline at pH 4.5 for a few minutes before
observations by ¯uorescence microscopy (21). Inhibition
assays were performed by preincubating COS-7 transfectants
with b-glucan, 2000 kDa dextran (both at 100 mg/ml) or
mannan (at 100, 500 or 1000 mg/ml) for 15 min at 4°C, and then
continuing the culture by adding Texas Red±zymosan for
another 3 h. The number of captured zymosan particles was
enumerated under the ¯uorescence microscope after visualiz-
ing cells expressing lectins by staining with Abs as described
above. At least 200 FITC+ transfectants were examined, and
cells capturing more than two particles were taken as positive.
The index was calculated as the average number of captured
zymosan particles per FITC+ cell.
Zymosan-binding assay of CHO-SIGNR1 transfectants and
peritoneal cells
For binding assays with transfectants at 4°C, CHO cells that
stably expressed whole SIGNR1 or SIGNR1 lacking 47
N-terminal amino acids including putative adopter protein-
binding sites (called #48) (13) were used, because cell
membrane of the transient transfected cells was fragile for
binding assay. The stable transfectants were mixed at 2 3 105/
well with 8 3 105/well FITC±zymosan in 100 ml of Hanks'-
balanced saline solution (HBSS) containing 1% FCS and 0.1%
NaN3 in V-bottomed 96-well plates and centrifuged at 250 g
for 5 min. After incubation for 4 h on ice, the cells were
suspended and analyzed with ¯ow cytometry. For inhibition
assay, 1 mg/ml of mannan, laminarin (Sigma-Aldrich: #L-9634)
or 20 mM EDTA was added and incubated for 1 h prior to the
addition of FITC±zymosan.
Resident peritoneal cells were obtained by injecting ice-
cold PBS containing 5 mM EDTA. After washing, cells were
preincubated with anti-CD16/32 mAb for 30 min for Fc-block
and stained with PE±CD11b (clone M1/70; BD PharMingen,
San Diego, CA) and biotin±ER-TR9 (BMA Biomedicals, Augst,
Switzerland) (22) followed by streptavidin±Cy-Chrome (BD
PharMingen) to detect SIGNR1 expression. Biotin±DX5
(CD49b; BD PharMingen) was used as an isotype-matched
control. For binding assays, bulk resident peritoneal cells were
®rst blocked for Fc-binding and stained with PE-labeled anti-
CD11b. Then the cells were mixed with FITC±zymosan at four
particles/cells and spun in V-bottomed 96-well plates as
above. Inhibition assay was also performed by preincubating
the cells in the presence of 1 mg/ml of mannan or laminarin,
25 mg/ml of ER-TR9 (Bachem Bioscience, King of Prussia, PA)
or rat IgM (clone R4-22; BD PharMingen) on ice for 1 h before
the assay.
Results
Internalization by antibody cross-linking
We ®rst studied the internalization of mouse DC-SIGN,
SIGNR1, SIGNR3 and Langerin molecules using HEK293T
transfectants with C-terminus Tag. As shown in Fig. 1(A),
nearly 90% of cells expressed lectins at comparable level.
Ligation of the lectins with the antibody resulted in the
reduction of the cell surface lectins, demonstrating the
internalization. However, the ef®ciency was greatest for
SIGNR3 and Langerin, which were taken up more rapidly
than mDC-SIGN and SIGNR1 (Fig. 1B, left panel). When
secondary Ab was added to facilitate cross-linking, more
rapid and ef®cient internalization was observed for all lectins,
with Langerin being a little more ef®cient than SIGNR3 (Fig. 1B,
right panel).
By deconvolution microscopy, the internalized anti-Tag
mAbs in NIH3T3 transfectants were observed in numerous
vesicles, of which some were double labeled with anti-
transferrin receptor mAb to mark early endosomes (Fig. 1C,
left panels). Consistent with the results of Fig. 1(B), relatively
large amounts of SIGNR1 and mDC-SIGN remained on the cell
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surface (Fig. 1C), even after 1 h incubation. All of the lectins
were localized in LAMP-2 negative non-lysosomal compart-
ments (Fig. 1C, right panels), as reported for hDC-SIGN
(23,24).
Different sugar recognition by the lectins
We next examined the endocytosis of FITC±dextran and FITC±
OVA using HEK293T cell transfectants expressing the
N-terminal-tagged lectins, since both dextran and OVA bind
to macrophage mannose receptors via an EPN motif in one of
the CRDs (16,17). Total expression levels of the lectins in
transfectants were tested by intracellular staining with anti-tag
antibody (Fig. 2A). As shown in Fig. 2(B), none of the
transfectants showed uptake for small 4.3 kDa FITC±dextran.
mDC-SIGN was also unable to endocytose any of the larger
FITC±dextrans, even though mDC-SIGN was internalized
following cross-linking with the monoclonal antibody
(Fig. 1B). Likewise, mDC-SIGN failed to take up FITC±OVA.
In contrast, SIGNR3 and Langerin took up 40 kDa FITC±
dextran, the form that is often used for endocytosis assays.
However, SIGNR1 endocytosed only the larger FITC±
dextrans, 250 kDa or more. Similar results were also obtained
when the transfectants were incubated at 1/10 of concentra-
tion of 40 or 2000 kDa FITC±dextran but for 12 h (data not
shown). Cells transfected with control plasmid were negative
for the uptake of any size of FITC±dextran. FITC±OVA, a
glycosylated protein, was also taken up by SIGNR1, SIGNR3
and Langerin, but not by mDC-SIGN (Fig. 2B, bottom-right
panel).
The effects of sugar inhibitors on FITC±dextran uptake were
also investigated (Fig. 2C). Mannan completely blocked FITC±
dextran uptake via any the lectins tested, even at the same
concentration as FITC±dextran. In contrast, excess amounts of
b-glucan and GalNAc were unable to inhibit endocytosis of
FITC±dextran. A large dose (~1.6 mg/ml) of fucose substan-
tially reduced their FITC±dextran uptake, while GlcNAc was
only inhibitory for SIGNR1 (57.8 6 1.7%) and Langerin (43.6 6
2.6%), but not for SIGNR3. These results for Langerin were
comparable to competition data using radio-labeled man-
nose-bound BSA by Stambach et al. (25). In addition, the
Fig. 1. Internalization of mouse DC-SIGN homologues and Langerin by antibody cross-linking. (A) HEK293T cells were transfected with V5 C-
terminal tagged-lectins. Cell surface expression of the lectins was checked using anti-V5 tag antibody. (B) The transfectants were treated with
(left panel) anti-V5 antibody or (right panel) anti-V5 antibody followed by biotin±donkey F(ab¢)2 anti-mouse IgG antibody. Following washing,
cells were incubated for the indicated time points at 37°C, and the antibodies remaining on the cell surface were visualized by staining with
biotin±donkey F(ab¢)2 anti-mouse IgG antibody and PE±streptavidin (left panel) or PE±streptavidin (right panel). Internalization is given by the
percentage of MFI in experimental groups relative to control samples at 4°C. The MFIs in the control groups of (left panel) and (right panel)
were 86 and 92 for SIGNR1, 62 and 55 for SIGNR3, 86 and 82 for mDC-SIGN and 46 and 43 for Langerin, respectively. (C) NIH3T3
transfectants expressing C-terminal tagged-lectins were treated with anti-V5 antibody. After 60 min incubation at 37°C, the anti-V5 antibodies
were visualized with biotin±donkey F(ab¢)2 anti-mouse IgG antibody followed by Texas Red±streptavidin. To localize the internalized
antibodies, the transfectants were also stained with anti-transferrin receptor (TfR) or anti-LAMP-2.
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monosaccharide speci®city for SIGNR1 and Langerin was
similar to those for other C-type lectins, such as mannose
receptor, serum mannose-binding protein and hDC-SIGN (26±
28). Thus, these results indicate that SIGNR3 has distinct
speci®city from SIGNR1 and Langerin. The oligosaccharide
sequences recognized by these three lectins have been
investigated in detail (C. Galustian, C. G. Park, W. Chai,
M. Kiso, S. A. Bruening, Y. S. Kang, R. M. Steinman and
T. Feizi, submitted for publication).
More precise analysis was performed for the inhibition by
mannan of FITC±dextran uptake via SIGNR1, SIGNR3 and
Langerin (Fig. 2D). FITC±dextran was most ef®ciently blocked
by mannan in the case of Langerin, followed by SIGNR1 and
SIGNR3. To extend these data, lectin binding assays for
Fig. 2. Comparison of internalization capacities for FITC±dextran and FITC±OVA as well as binding af®nity for mannan. (A) Expression of
SIGNR1, SIGNR3, mDC-SIGN and Langerin in transfectants were checked using anti-Xpress tag antibody. Open histogram indicates a control
staining of transfectants with the parental plasmid. (B) The transfectants were incubated with various molecular weights of FITC±dextran for 1 h
or FITC±OVA for 12 h (bottom right panel). Open histograms indicate background uptake by transfected cells with the parental plasmid. The
results shown are representative of ®ve independent experiments. (C) Inhibition of FITC±dextran (molecular weight 2000 kDa) uptake by
soluble carbohydrates in HEK293T cell transfectants. Cells were incubated with 1±1003 higher concentrations of soluble b-glucan, mannan,
GalNAc and GlcNAc for 15 min before incubation with 16 mg/ml FITC±dextran for 1 h. Inhibition is indicated as the percent decrease of FITC+
cells in experimental groups compared to respective controls without blocking sugars. FITC+ cells in control groups were 72% for SIGNR1,
74% for SIGNR3 and 32% for Langerin. A representative result from four independent experiments is shown. (D) Titration of the inhibitory
effect by mannan. The FITC±dextran uptake was inhibited by graded amounts of mannan. The relative amount shown as `1' indicates 16 mg/ml
mannan. (E) Mannan binding properties of the lectins. Cell lysates of the HEK293T transfectants were incubated with mannan±agarose. Bound
protein was detected by western blotting using anti-Xpress or anti-SIGNR1 antibody with/without EDTA.
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mannan±agarose were carried out using cell lysates of the
transfectants. We found that Langerin and SIGNR1, but not
SIGNR3, bound mannan in a Ca2+-dependent manner
(Fig. 2E). Although SIGNR1 appeared to capture mannan
less ef®ciently than Langerin, this result was not conclusive
since the amounts of lectins were not adjusted.
SIGNR1, SIGNR3 and Langerin capture zymosan via its
mannan moiety
Mannan is the major constituent of zymosan and is recognized
by mannose-binding receptors (29,30). Thus the recognition
and uptake of FITC±zymosan was studied. For this
experiment, we used COS-7 cells because their large size
permits easier observation of zymosan binding/internalization
under the microscope. Similar to the data with 2000 kDa FITC±
dextran and FITC±OVA, transfectants of SIGNR1, SIGNR3 and
Langerin were capable of capturing a large number of
zymosan particles (Fig. 3A) and heat-killed C. albicans
(Fig. 3B). For DC-SIGN, only a small number of the
transfectants, if any, could bind a few yeast particles (data
not shown). The internalization function of SIGNR1 and
SIGNR3 was also con®rmed using trypan blue quenching
method for FITC±zymosan (Fig. 3C). This treatment reduced
the percentages of FITC+ zymosan-bearing SIGNR1- and
Fig. 3. Capture of yeast and yeast-like particles zymosan. COS-7 transfectants of N-terminal tagged-SIGNR1, SIGNR3, DC-SIGN and
Langerin were incubated with Texas Red±zymosan (A) for 12 h and C. albicans (B) for 4 h. Lectins expressed by the transfectants were
visualized with anti-Xpress Tag antibody. Internalization of FITC±zymosan was con®rmed by quenching ¯uorescence using treatment with
trypan blue. (C) Intracellular zymosan particles stayed brightly positive for FITC, whereas extracellular ones largely lost ¯uorescence by trypan
blue (arrows). (D) COS-7 transfectants of SIGNR1, SIGNR3 and Langerin were preincubated with b-glucan, dextran or mannan before adding
zymosan particles. After staining with anti-Xpress mouse IgG antibody followed by biotin±donkey F(ab¢)2 anti-mouse IgG antibody + FITC±
streptavidin, cells capturing more than two zymosan particles were regarded as positive cells, and only the numbers of particles in positive
cells were counted. Index denotes the number of particles per cell in more than 200 transfectants. Left and middle panels show results with
the inhibitors at 100 mg/ml. Right panel indicates that a higher amount of mannan is required for inhibition in the case of SIGNR1 transfectants.
Result shown is representative of three separate experiments.
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SIGNR3-transfected cells from 75±85% to 15±30%. Control
transfectants with the parental plasmid were negative for
capture of zymosan. Therefore, SIGNR1 and SIGNR3 can
internalize zymosan, although uptake was moderate in our
transfectants.
The blocking of zymosan uptake was also tested using
mannan and b-glucan as inhibitors, since a large part of the
yeast cell wall is composed of mannan, b-glucan and chitin
(29). Although mannan at 100 mg/ml completely abrogated
FITC±dextran uptake via SIGNR1 (Fig. 2C), an only slight
inhibition of zymosan uptake was detected at the same dose of
mannan (Fig. 3D, left and middle panels). However, a large
excess of mannan (500 and 1000 mg/ml) signi®cantly reduced
zymosan capture by SIGNR1 (Fig. 3D, right panel). In contrast
to SIGNR1, mannan was still a potent inhibitor for zymosan
uptake by SIGNR3 and Langerin. b-glucan had no effect on
SIGNR1 and SIGNR3, but substantially inhibited the activity of
Langerin. On the other hand, dextran signi®cantly inhibited
SIGNR3- and Langerin-mediated capture of zymosan.
Capture of Gram-negative bacterial by SIGNR1, but not the
other lectins tested
In striking contrast to the data with FITC±zymosan, Gram-
negative bacteria, such as E. coli and S. typhimurium, were
captured, but only by SIGNR1 transfectants, and not by the
other C-type lectin transfectants (Fig. 4A and B). On the other
hand, the Gram-positive bacterium Staphylococcus aureus
was not captured by any type of transfectants examined here
(data not shown).
Zymosan capture by SIGNR1-tranfectant is mediated via the
recognition for mannan moiety
Because of the broad speci®city of SIGNR1 for microbes, we
attempted to detect direct binding of zymosan by SIGNR1
transfectants at 4°C. For this purpose, CHO cells stably
expressing intact or truncated SIGNR1 (#48) were utilized. As
shown in Fig. 5(A), both transfectants effectively and
comparably bound FITC±zymosan (72±78%), and the treat-
ment with mannan and EDTA, but not laminarin, resulted in a
complete block of zymosan binding to control levels (~6%).
Expression of SIGNR1 and zymosan binding by a
subpopulation of resident peritoneal cells
As reported previously, SIGNR1 protein is expressed by
macrophages in spleen and lymph nodes (13). SIGNR1+
marginal zone macrophages play a role in capturing
Streptococcus pneumoniae (15). Although we are able to
obtain such SIGNR1+ macrophages from spleen, it is dif®cult
to prepare a large number of SIGNR1+ macrophages using
conventional methods. We therefore sought another source of
SIGNR1+ cells using monoclonal antibody ER-TR9 (22), and
found that 75% or more of CD11b+ cells in the resident
peritoneal cavity express SIGNR1 (Fig. 5B, left and center
panels). This made it possible to examine a role of SIGNR1
zymosan recognition by direct binding assays at 4°C. About
Fig. 4. Capture of Gram-negative bacteria. COS-7 transfectants were incubated with Texas Red±E. coli (A) for 12 h or FTIC±S. typhimurium
(B) for 6 h. Lectins expressed by the transfectants were visualized as in Fig. 3.
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45% of CD11b+ peritoneal cells were able to bind FITC±
zymosan (Fig. 5B, right panel), and this binding was signi®-
cantly inhibited by SIGNR1-speci®c ER-TR9 mAb (Fig. 5C). An
excess of mannan was effective, although both ER-TR9 and
mannan did not completely inhibit, as in Fig. 5(A). Since
macrophages are known to express other C-type lectins with
different carbohydrate speci®city, such as Dectin-1 recogniz-
ing b-glucan on zymosan, laminarin, a known ligand for
Dectin-1 was used as an inhibitor (31). Laminarin itself blocked
zymosan binding to SIGNR1+ peritoneal cells, and the
blocking was augmented by co-addition of mannan (Fig. 5C).
Similar results were also obtained using heat-killed C. albicans
(data not shown). Therefore, it is likely that SIGNR1 and a
laminarin-sensitive receptor, possibly Dectin-1, on a popula-
tion of peritoneal cells cooperate to bind zymosan by
recognizing different carbohydrate moieties.
Discussion
In the present study, we demonstrate the distinctive uptake of
polymerized dextran, glycosylated protein and microbes, as
well as the binding capacity to mannan and zymosan, by
C-type lectins in the mouse DC-SIGN family (DC-SIGN,
SIGNR1 and SIGNR 3) and Langerin, of which all share an
EPN-motif in their CRD. Results are summarized in Table 1.
For the presentation of exogenous antigens, it is necessary
to internalize and deliver them to LAMP-2-positive late
endosome/lysosome compartments, where processed anti-
gens are loaded onto MHC class II molecules. These four
lectins on the cell surface of transfectants could each be
internalized by cross-linking with speci®c antibody in HEK293
T cell and NIH3T3 transfectants. However, the internalized
antibodies were detected in cytoplasmic compartments lack-
ing LAMP-2 in NIH3T3 transfectants. As for SIGNR1,
Geijtenbeek et al. (14) recently suggested a rapid sorting of
FITC±dextran captured by SIGNR1 into lysosome-like com-
partments using an erythroleukemic cell line K562, although
they did not double label with a lysosomal marker. In contrast,
we ®nd that internalized FITC±dextran is delivered to com-
partments lacking LAMP-1/CD107a, pan-lysosomal maker,
using stably transfected RAW264.7 SIGN-R1 transfectants
(13). These discrepancies may depend on cell types tested. In
human DCs, however, Langerin is also reported to deliver
bound mAb to non-lysosomal compartments (32), while DC-
SIGN sorts captured mycobacteria and speci®c mAb into
lysosomal compartments (9). Therefore, it is also possible that
adaptor proteins for each lectin are involved in internalization
and intracellular sorting.
Our results show that the ef®cacy of uptake of bound mAb
varies amongst the lectins. The results of Fig. 1(B) are
consistent with those of Fig. 1(C) where DC-SIGN and
SIGNR1 are less ef®cient for internalization than SIGNR3 and
Langerin. These distinctions may re¯ect differences in the
cytoplasmic tails. It has been shown that mDC-SIGN and
SIGNR1 have a single dileucine motif (DEELL and DDDELM,
respectively), which binds adaptor proteins for the clathrin-
coated pit, while SIGNR3 has both a dileucine motif and
tyrosine internalization motif (DEECLM and YSDI) (12).
Langerin has a distinct type of proline-rich sequence
(PREPPP) that may bind a signal protein containing a src
homology 3 (SH3) domain (33), leading to a rapid internaliza-
tion by cross-linking with anti-Langerin mAb (32). Examination
of internalization ef®ciency of these lectins using transfectants
of other cell types remains to be conducted. Regarding uptake
of polymerized FITC±dextran, mDC-SIGN was found to be
inactive even for high molecular weight forms (although mDC-
SIGN was capable of internalizing a ligated mAb as men-
tioned). Furthermore, none of the microbes tested were
captured by mDC-SIGN. In contrast, SIGNR3 and Langerin
were capable of ef®ciently taking up FITC±dextran even with a
Fig. 5. Direct binding of stably SIGNR1-transfected CHO cells and
of resident peritoneal cells expressing SIGNR1. (A) SIGNR1 itself
bound FITC±zymosan in a mannan and EDTA-sensitive manner.
CHO-SIGNR1 and CHO-#48 cells lacking the cytoplasmic tail of
SIGNR1 were incubated with FITC±zymosan on ice with/without
inhibitors described. Reduction of FITC±zymosan capture by
inhibitors is depicted in the right panel. (B) Expression of SIGNR1 on
resident peritoneal cells was analyzed by ¯ow cytometry. A majority
of CD11b+ cells were stained with ER-TR9, anti-SIGNR1 mAb (left
and center panels). Open histogram represents control staining with
DX-5 antibody. The CD11b+ cells were capable of binding FITC±
zymosan at 4°C (right panel). (C) Cooperation in zymosan binding
by SIGNR1 and laminarin-sensitive receptor. Peritoneal cells were
pretreated with inhibitors represented for 1 h. Binding (%) indicates
the percentage of FITC+ cells in CD11b+ cells.
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small molecular weight. SIGNR1, however, could only take up
highly polymerized dextran. Moreover, uptake of high
molecular weight FITC±dextran was blocked by mannan with
an ef®cacy order of Langerin > SIGNR1 > SIGNR3, and direct
binding to mannan±agarose was only detected with Langerin
and SIGNR1, but not DC-SIGN and SIGNR3, in a Ca2+-
dependent manner. These observations and the results
showing distinctive blocking ef®ciency with free mono-
saccharides for FITC±dextran uptake, indicate that the lectins
tested here have characteristic sugar recognition abilities,
even though they share a common EPN motif in their single
CRD domains.
SIGNR1, SIGNR3 as well as Langerin could also capture
zymosan and C. albicans. However, capture via Langerin was
much more ef®ciently inhibited not only by mannan but also by
b-glucan and polymerized dextran, than that via SIGNR1 and
SIGNR3. Furthermore, Langerin-mediated capture was the
lowest among these three lectins, in terms of the number of
zymosan particles captured per transfectant. On the other
hand, the capture via SIGNR1 was not much affected by
mannan, even though CRDs of SIGNR1 and SIGNR3 are
homologous; 69.9% in amino acid sequence. This might be
ascribed to the difference in their avidity for mannan, but this
possibility is unlikely, since mannan was more potent in
blocking the uptake of FITC±dextran by SIGNR1 than that by
SIGNR3. Another possibility is that SIGNR1 and SIGNR3
recognize different target moieties on zymosan particles,
since dextran was more effective in inhibiting the capture of
zymosan by SIGNR3. Alternatively, SIGNR1 might recognize a
particular spatial arrangement or pattern of target sugars on
the zymosan particles. It has been reported that the binding
speci®cities of hDC-SIGN and L-SIGN might be generated by
the spatial arrangement of target sugars in high mannose
oligosaccharides (27,34). We also demonstrated that SIGNR1
molecules primarily exist in aggregated form in situ (13).
Furthermore, the potency to bind zymosan through the
recognition of mannan was also shown in SIGNR1-transfected
CHO cells. This binding was dependent on Ca2+, but did not
require the cytoplasmic tail. Therefore, SIGNR1 may have a
higher avidity to multivalent/repetitive target sugars spaced on
zymosan.
Interestingly, SIGNR1 was able to capture Gram-negative
bacteria, such as E. coli and S. typhimurium, but not Gram-
positive bacteria; S. aureus in the present study. However,
we previously reported that capsular polysaccharide of
Streptococcus pneumoniae, Gram-positive bacteria, can be
recognized by SIGNR1 (15). This discrepancy has yet to be
solved, but may be ascribed to the loss or damage of capsule
of ¯uorescence-labeled S. aureus available on the market.
At present, we cannot exclude the possibility that poly-
saccharide and microbial uptake could be somehow in¯u-
enced by intracellular tag. However, SIGNR1, SIGNR3 and
Langerin with intracellular tag are competent for uptake of
dextran and OVA, and their endocytic capacity is dependent
on ligand and its structure. Therefore, we suspect the effect of
the expression tag on endocytic activity.
Recently, Dectin-1, a b-glucan receptor, has been reported
to collaborate with Toll-like receptor (TLR) 2 to recognize
Table 1. Summary of carbohydrate recognition abilities of SIGNR, SIGNR3, mDC-SIGN and Langerin
Lectins
Inhibitor SIGNR1 SIGNR3 mDC-SIGN Langerin
Internalization
Ligation with anti-Tag mAb + +++ ++ +++
Capture of antigen
FITC±OVA ++ ++ 6 +++
FITC±dextran
4.3 kDa ± ± ± ±
40 kDa ± ++ ± +
250 kDa ++ +++ ± ++
2000 kDa +++ +++ ± ++
Inhibition by Mannan *** *** N.T. ***
GalNAc * * N.T. *
GlcNAc ** * N.T. **
Fucose ** ** N.T. **
Capture of zymosan
Binding +++ +++ N.T. ++
Inhibition by Mannan ** *** N.T. ***
Dextran ** ** N.T. **
b-glucan * * N.T. *
Uptake ++ ++ N.T. N.T.
Capture of bacteria
E. coli +++ ± N.T. ±
S. typhimurium +++ ± N.T. ±
±, negative; 6, very weak but not negative; + ® +++, positive ® strongly positive; * no obvious effect; ** moderate inhibition; *** strong
inhibition; N.T., not tested.
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microbes for in¯ammatory response (35,36). Therefore, it will
be of interest to elucidate the involvement of other pattern
recognition receptors, such as TLRs, for the recognition of
Gram-negative bacteria in collaboration with SIGNR1. In
addition, results showing cooperative recognition of yeast by
SIGNR1 and laminarin-sensitive receptor (possibly Dectin-1)
on peritoneal cells may lead us to anticipate more complicated
regulation in pattern recognition systems in situ. During
revision of this manuscript, similar results demonstrating
participation of both SIGNR1 and Dectin-1 for recognizing
zymosan were reported by Taylor et al. (37). The different
properties of mouse DC-SIGN, SIGNR1, SIGNR3 and
Langerin indicate that distinct microbial components are
recognized by lectins expressed by cells of the innate immune
system.
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